Infinity Pharmaceuticals Inc (INFIQ)

[crudeoil24]

Analyst Jim Birchenough is bullish on the company following selection of IPI-549 monotherapy data as a late breaker oral presentation at SITC annual meeting next month. The analyst comments "Based on prior SITC late breaker data we see a reasonable likelihood of proof-of-concept response rate data, and with likely validation of tumor macrophage targeting in immunooncology (IO) and a unique mechanism of action we see upside potential not reflected at current stock price."